These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Author: Byerley WF, Reimherr FW, Wood DR, Grosser BI.
    Journal: J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684.
    Abstract:
    In a double-blind, placebo-controlled study the authors found that fluoxetine, a potent and selective inhibitor of serotonin reuptake, was an effective antidepressant in moderately depressed, ambulatory outpatients. Typical adverse effects reported by patients treated with fluoxetine included agitation, nausea, fatigue, and insomnia. Compared to imipramine, fluoxetine was associated with fewer complaints of dry mouth, constipation, and dizziness.
    [Abstract] [Full Text] [Related] [New Search]